Ravinder Kodela

NOSH-Aspirin: A Novel Nitric Oxide–Hydrogen Sulfide-Releasing Hybrid: A New Class of Anti-inflammatory Pharmaceuticals

Ravinder Kodela, Mitali Chattopadhyay, Khosrow Kashfi · ACS Medicinal Chemistry Letters · 2012 · 173 citations

Medicinal Chemistry, Pharmaceutical Science, Heterocyclic +15

Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: A general property and evidence of a tissue type-independent effect

Mitali Chattopadhyay, Ravinder Kodela, Niharika Nath et al. · Biochemical Pharmacology · 2011 · 129 citations

Human Cancer Cells, Anti-inflammatory, Biochemistry +8

NOSH–aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model

Mitali Chattopadhyay, Ravinder Kodela, Kenneth R. Olson et al. · Biochemical and Biophysical Research Communications · 2012 · 127 citations

Hydrogen Sulfide-releasing Hybrid, Xenograft Mouse Model, Medicine +8

Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo

Mitali Chattopadhyay, Ravinder Kodela, Niharika Nath et al. · Biochemical Pharmacology · 2011 · 96 citations

Molecular Pharmacology, Cancer Research, Breast Oncology +12

14,15-Epoxyeicosa-5,8,11-trienoic Acid (14,15-EET) Surrogates Containing Epoxide Bioisosteres: Influence upon Vascular Relaxation and Soluble Epoxide Hydrolase Inhibition

John R. Falck, Ravinder Kodela, R Manne et al. · Journal of Medicinal Chemistry · 2009 · 82 citations · Full text